Carecapital Stocks Up 145% At AGM

CareCapital Group (LSE:CARE) shares rose a stellar 145% today following the release of their annual trading update for presentation at the company’s Annual General Meeting today.

Operations Update

Although previously approved by the shareholders, the commentary in the Trading Update regarding the November 2011 sales of their entire German operations portfolio laid a solid foundation for the unfolding company plans and potential ROI for investors. The transaction freed up €27.35 millon to provide working capital to be used in the development of UK interests.

Company Plans

Chairman Mike Sinclair indicated that the company will not be renewing its lease for its current head office location in London. This decision, bundled with several other initiatives, is expected to generate cost savings of at least £250,000 annually.

The Board of Directors indicated solid confidence that the company’s 28.75% share in Advanced Proton Solutions will have “significant value” as the demand for the cancer treatment procedure increases worldwide.

The company is also entertaining and evaluating overtures from several other providers of proven cancer treatments. It has given some consideration to alliances that could form the basis for a new healthcare division for the company.

Chairman Statement

Mike Sinclair’s summary statement was no doubt music to investors’ ears: “We are now, I believe, making good progress towards our objective of restoring value to shareholders.”

Company Spotlight

CareCapital is a comprehensive property and service solutions providing customised healthcare facilities in partnership with the National Health Serice (NHS) and other healthcare providers in the United Kingdom and Europe.

References
↑ Company website

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

WHAT IS ADVFN?

ADVFN covers all things stock market.

From the news and opinion pieces on pages like this to share discussion forums, charting tools, financials, live share prices and Level 2, order book data

If you trade or invest ADVFN has the tools you need to make the right decisions.

• 

  101 Ways to Pick Stock Market Winners

  You need the number one bestselling investment guide, the definitive text for day traders, investors and stock pickers.

• 

  The Death of Wealth

  Dissecting the global economy and the financial markets, the book lays out the evidence for the next economic game changer: the Death of Wealth.

• 

  Beth Anne Lamar

• 

  Tom Frew

• 

  Neto Trade Analysis Department

• 

  Robbie Burns